← Leaderboards
Yong Huang
University Of California, San Francisco
$6,295,990
Attributed
$6,295,990
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2009–16$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$6,295,990 · 5
By mechanism
N01$6,295,990 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Valerie Marie Weaver$26,171,723
- Radojka Savic$8,230,011
- Payam Nahid$19,473,523
- Nola M. Hylton$19,153,972
- Allan I Basbaum$21,405,713
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBiologicalContractsDrug KineticsNational Institute Of Drug AbuseMetabolismResearch PersonnelPlasmaClinical TrialsAnalytical MethodResourcesServicesProtein BindingToxicologyPharmacologic SubstanceResearch And DevelopmentPharmacologyDrug AddictionDesignMetabolic Abnormality AssessmentLiquid SubstanceMolecularAdme StudyLaboratories
Grant awards (20)
Pharmacokinetic and Pharmacological Studies of Antitumor and other Therapeutic Agents$94,188
N01 · FY2016 · CA · contact PI
IGF::OT::IGF Non-Clinical ADME Studies, POP 5/2/14-05/1/16PURPOSE To amend the period of performance for Option Period 2 from 05/02/2016-05/01/2017 to 05/02/2016-06/30/2016 and to exercise Opti$20,790
N01 · FY2016 · DA · contact PI
IGF::OT::IGF, FY 2014, POP 5/2/2014-5/1/2015, N01DA-14-8916, Non-Clinical ADME Studies, Option Quantity 5 exercised 5 times.$213,917
N01 · FY2015 · DA · contact PI
Analytical Services Center for Medications Development Program$199,158
N01 · FY2015 · DA · contact PI
Pharmacokinetic and Pharmacological Studies of Antitumor and other Therapeutic Agents$31,396
N01 · FY2015 · CA · contact PI
Analytical Services Center for Medications Development Program$532,615
N01 · FY2014 · DA · contact PI
IGF::OT::IGF, FY 2014, POP 5/2/2014-5/1/2015, N01DA-14-8916, Non-Clinical ADME Studies, Option Quantity 5 exercised 5 times.$417,691
N01 · FY2014 · DA · contact PI
Pharmacokinetic and Pharmacological Studies of Antitumor and other Therapeutic Agents$62,601
N01 · FY2014 · CA · contact PI
Analytical Services Center for Medications Development Program$100,000
N01 · FY2013 · DA · contact PI
Preclinical Pharmacokinetic and Pharmacological Studies of Antitumor and other Th$93,783
N01 · FY2013 · CA · contact PI
ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT$761,477
N01 · FY2012 · DA · contact PI
Non-Clinical ADME Studies$480,558
N01 · FY2012 · DA · contact PI
Preclinical Pharmacokinetic and Pharmacological Studies of Antitumor and other Th$153,333
N01 · FY2012 · CA · contact PI
ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT$700,089
N01 · FY2011 · DA · contact PI
Non-Clinical ADME Studies$556,207
N01 · FY2011 · DA · contact PI
Preclinical Pharmacokinetic and Pharmacological Studies of Antitumor and other Th$50,000
N01 · FY2011 · CA · contact PI
Non-Clinical ADME Studies$481,063
N01 · FY2010 · DA · contact PI
ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT$448,232
N01 · FY2010 · DA · contact PI
Non-Clinical ADME Studies$481,932
N01 · FY2009 · DA · contact PI
ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT$416,960
N01 · FY2009 · DA · contact PI